Alterations in hair follicle dynamics in women

Claudine Piérard-Franchimont, Gérald E Piérard, Claudine Piérard-Franchimont, Gérald E Piérard

Abstract

Endocrine changes supervening after parturition and menopause participate in the control of sebum production and hair growth modulation. The ensuing conditions include some peculiar aspects of hair loss (effluvium), alopecia, and facial hirsutism. The hair cycling is of major clinical relevance because most hair growth disorders result from disturbances in this chronobiological feature. Of note, any correlation between a biologic abnormality and hair cycling disturbance does not prove a relationship of causality. The proportion of postmenopausal women is rising in the overall population. Therefore, the prevalence of these hair follicle disturbances is globally on the rise. Current therapies aim at correcting the underlying hormonal imbalances, and at improving the overall cosmetic appearance. However, in absence of pathogenic diagnosis and causality criteria, chances are low that a treatment given by the whims of fate will adequately control hair effluvium. The risk and frequency of therapeutic inertia are further increased. When the hair loss is not controlled and/or compensated by growth of new hairs, several clinical aspects of alopecia inexorably develop. Currently, there is little evidence supporting any specific treatment for these endocrine hair disorders in post-partum and postmenopausal women. Current hair treatment strategies are symptomatic and nonspecific so current researchers aim at developing new, targeted methods.

Figures

Figure 1
Figure 1
Growing hair in anagen phase with numerous cells in S phase of proliferation in the hair bulb and a few others in the dermal papilla. Tritiated thymidine autoradiography.

References

    1. Piérard GE, Piérard-Franchimont C, Marks R, Elsner P. EEMCO guidance for the assessment of hair shedding and alopecia. Skin Pharmacology and Physiology. 2004;17:98–110.
    1. Schneider MR, Schmidt-Ullrich R, Paus R. The hair follicle as a dynamic miniorgan. Current Biology. 2009;19(3):R132–R142.
    1. Paus R, Foitzik K. In search of the “hair cycle clock”: a guided tour. Differentiation. 2004;72(9-10):489–511.
    1. Botchkarev VA, Paus R. Molecular biology of hair morphogenesis: development and cycling. Journal of Experimental Zoology B. 2003;298(1):164–180.
    1. Stenn KS, Paus R. Controls of hair follicle cycling. Physiological Reviews. 2001;81(1):449–494.
    1. Paus R, Arck P, Tiede S. (Neuro-)endocrinology of epithelial hair follicle stem cells. Molecular and Cellular Endocrinology. 2008;288(1-2):38–51.
    1. Stenn KS, Paus R. What controls hair follicle cycling? Experimental Dermatology. 1999;8(4):229–236.
    1. Al-Nuaimi Y, Baier G, Watson RE, Chuong C-M, Paus R. The cycling hair follicle as an ideal systems biology research model. Experimental Dermatology. 2010;19(8):707–713.
    1. Tobin DJ, Foitzik K, Reinheckel T, et al. The lysosomal protease cathepsin L is an important regulator of keratinocyte and melanocyte differentiation during hair follicle morphogenesis and cycling. The American Journal of Pathology. 2002;160(5):1807–1821.
    1. Higgins CA, Westgate GE, Jahoda CA. From telogen to exogen: mechanisms underlying formation and subsequent loss of the hair club fiber. Journal of Investigative Dermatology. 2009;129(9):2100–2108.
    1. Higgins CA, Westgate GE, Jahoda CA. Modulation in proteolytic activity is identified as a hallmark of exogen by transcriptional profiling of hair follicles. Journal of Investigative Dermatology. 2011;131(12):2349–2357.
    1. Stenn KS, Paus R. Controls of hair follicle cycling. Physiological Reviews. 2001;81(1):449–494.
    1. Piérard-Franchimont C, Piérard GE. Teloptosis, a turning point in hair shedding biorhythms. Dermatology. 2001;203(2):115–117.
    1. Piérard-Franchimont C, Paquet P, Quatresooz P, Piérard GE. Mechanobiology and cell tensegrity: the root of ethnic hair curling? Journal of Cosmetic Dermatology. 2011;10(2):163–167.
    1. Elliott K, Stephenson TJ, Messenger AG. Differences in hair follicle dermal papilla volume are due to extracellular matrix volume and cell number: implications for the control of hair follicle size and androgen responses. Journal of Investigative Dermatology. 1999;113:873–877.
    1. Baque CSO, Zhou J, Gu W, et al. Relationships between hair growth rate and morphological parameters of human straight hair: a same law above ethnical origins? International Journal of Cosmetic Science. 2012;34(2):111–116.
    1. Du Cros DL, LeBaron RG, Couchman JR. Association of versican with dermal matrices and its potential role in hair follicle development and cycling. Journal of Investigative Dermatology. 1995;105(3):426–431.
    1. Hsu Y-C, Pasolli HA, Fuchs E. Dynamics between stem cells, niche, and progeny in the hair follicle. Cell. 2011;144(1):92–105.
    1. Birch MP, Messenger JF, Messenger AG. Hair density, hair diameter and the prevalence of female pattern hair loss. British Journal of Dermatology. 2001;144(2):297–304.
    1. Courtois M, Loussouarn G, Hourseau C, Grollier JF. Ageing and hair cycles. British Journal of Dermatology. 1995;132(1):86–93.
    1. Courtois M, Loussouarn G, Hourseau C, Grollier JF. Hair cycle and alopecia. Skin Pharmacology. 1994;7(1-2):84–89.
    1. Piérard-Franchimont C, Petit L, Loussouarn G, Saint-Léger D, Piérard GE. The hair eclipse phenomenon: sharpening the focus on the hair cycle chronobiology. International Journal of Cosmetic Science. 2003;25(6):295–299.
    1. Messenger AG. Hair through the female life cycle. British Journal of Dermatology. 2011;165(supplement s3):2–6.
    1. Millikan L. Hirsutism, postpartum telogen effluvium, and male pattern alopecia. Journal of Cosmetic Dermatology. 2006;5(1):81–86.
    1. Eastham JH. Postpartum alopecia. The Annals of Pharmacotherapy. 2001;35(2):255–258.
    1. Piérard-Franchimont C, Piérard GE. Paroxismal reactions of the scalp. Revue Médicale de Liège. 2004;59:180–185.
    1. Roux C, Pelissier C, Fechtenbaum J, Loiseau-Peres S, Benhamou CL. Randomized, double-masked, 2-year comparison of tibolone with 17β-estradiol and norethindrone acetate in preventing postmenopausal bone loss. Osteoporosis International. 2002;13(3):241–248.
    1. Mirmirani P. Hormonal changes in menopause: do they contribute to a “midlife hair crisis” in women? British Journal of Dermatology. 2011;165(s3):7–11.
    1. Dinh QQ, Sinclair R. Female pattern hair loss: current treatment concepts. Clinical Interventions in Aging. 2007;2(2):189–199.
    1. Nelson HD. Menopause. The Lancet. 2008;371(9614):760–770.
    1. Sinclair R, Patel M, Dawson TL, et al. Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness. British Journal of Dermatology. 2011;165(supplement s3):12–18.
    1. Xhauflaire-Uhoda E, Piérard-Franchimont C, Piérard GE, Quatresooz P. Weathering of the hairless scalp: a study using skin capacitance imaging and ultraviolet light-enhanced visualization. Clinical and Experimental Dermatology. 2010;35(1):83–85.
    1. Piérard-Franchimont C, Piérard GE. Hair weathering and hair capacitance mapping: a pilot study. Journal of Cosmetic Dermatology. 2012;11:179–182.
    1. Dawn G, Holmes SC, Moffat D, Munro CS. Post-menopausal frontal fibrosing alopecia. Clinical and Experimental Dermatology. 2003;28(1):43–45.
    1. Tosti A, Piraccini BM, Iorizzo M, Misciali C. Frontal fibrosing alopecia in postmenopausal women. Journal of the American Academy of Dermatology. 2005;52(1):55–60.
    1. Rallis E, Gregoriou S, Christofidou E, Rigopoulos D. Frontal fibrosing alopecia: to treat or not to treat? Journal of Cutaneous Medicine and Surgery. 2010;14(4):161–166.
    1. Zargar AH, Wani AI, Masoodi SR, Laway BA, Bashir MI, Salahuddin M. Epidemiologic and etiologic aspects of hirsutism in Kashmiri women in the Indian subcontinent. Fertility and Sterility. 2002;77(4):674–678.
    1. Blume-Peytavi U, Atkin S, Gieler U, Grimalt R. Skin academy: hair, skin, hormones and menopause—current status/knowledge on the management of hair disorders in menopausal women. European Journal of Dermatology. 2012;22:310–318.
    1. Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients. The Journal of Clinical Endocrinology & Metabolism. 2004;89(2):453–462.
    1. Randall VA. Androgens and hair growth. Dermatologic Therapy. 2008;21(5):314–328.
    1. Dawber RP. Hirsuties. The Journal of Gender-Specific Medicine. 2002;5(5):34–42.
    1. Pauli S, Lobo RA. Polycystic ovary syndrome after menopause: a case report. The Journal of Reproductive Medicine. 2004;49:491–494.
    1. Rosenfield RL. Hirsutism. The New England Journal of Medicine. 2005;353:2578–2588.
    1. Mofid A, Seyyed Alinaghi SA, Zandieh S, Yazdani T. Hirsutism. International Journal of Clinical Practice. 2008;62(3):433–443.
    1. Al Robaee A, Al-Zolibani A, Al-Shobaili A, Aslam M. Update on hirsutism. Acta Dermatovenerologica Alpina Pannonica et Adriatica. 2008;17:103–119.
    1. Shah D, Patel S. Hirsutism. Gynecological Endocrinology. 2009;25(3):140–148.
    1. Bühler-Christen A, Tischler V, Diener P-A, Brändle M. New onset alopecia and hirsutism in a postmenopausal women. Gynecological Endocrinology. 2009;25(5):324–327.
    1. Diab DL, Faiman C, Siperstein AE, Zhou M, Zimmerman RS. Virilizing adrenal ganglioneuroma in a woman with subclinical Cushing syndrome. Endocrine Practice. 2008;14(5):584–587.
    1. Krug E, Berga SL. Postmenopausal hyperthecosis: functional dysregulation of androgenesis in climacteric ovary. Obstetrics & Gynecology. 2002;99(5):893–897.
    1. Kim Y, Marjoniemi V-M, Diamond T, Lim A, Davis G, Murrell D. Androgenetic alopecia in a postmenopausal woman as a result of ovarian hyperthecosis. Australasian Journal of Dermatology. 2003;44(1):62–66.
    1. Marcondes JAM, Curi DDG, Matsuzaki CN, et al. Ovarian hyperthecosis in the context of an adrenal incidentaloma in a postmenopausal woman. Arquivos Brasileiros de Endocrinologia & Metabologia. 2008;52(7):1184–1188.
    1. Wu DH, McMurtrie DG, Hirsch SD, Johnston CM. Postmenopausal hyperandrogenism caused by a benign cystic teratoma: a case report. The Journal of Reproductive Medicine. 2008;53:141–144.
    1. Braunstein GD. Management of female sexual dysfunction in postmenopausal women by testosterone administration: safety issues and controversies. The Journal of Sexual Medicine. 2007;4(4i):859–866.
    1. Gelfand MM. Role of androgens in surgical menopause. American Journal of Obstetrics & Gynecology. 1999;180(3, part 2):S325–S327.
    1. Piérard-Franchimont C, Quatresooz P, Piérard GE. Diagnostic defects and therapeutic set-backs in hair disorders. Revue Médicale de Liège. 2010;65:413–419.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться